ROCK1 and osteosarcoma: Using Kaplan-Meier method and log-rank test, the overall survival (OS, Figure 4A, both p < 0.001) and progression-free survival (PFS, Figure 4B, both p = 0.001) of pediatric osteosarcoma patients with low miR-340 expression or high ROCK1 expression were both significantly shorter than those with high miR-340 expression or low ROCK1 expression.